← All instruments
Dividend per share, restated for any split or bonus that came after — so a pre-split payout is comparable with a post-split one. FY17 is in progress: that bar shows what has been declared so far, not a full year.
Wockhardt Limited
StockNSE: WOCKPHARMA· Face value ₹5
₹1,916.50
▲ 1.40%
Delayed · as of 29 Jul 2026
Dividend per share by financial year
| Financial year | Total dividend |
|---|---|
| FY02 | ₹2.00 |
| FY03 | ₹4.33 |
| FY05 | ₹7.50 |
| FY07 | ₹5.00 |
| FY08 | ₹8.75 |
| FY09 | ₹2.50 |
| FY14 | ₹15.00 |
| FY15 | ₹20.00 |
| FY17 | ₹10.00 |
Dividend history
Source: NSE & BSE announcementsDownload CSV| Type | Amount (adjusted) | Ex-date | Record date | Payment date | FY | Confirmed by |
|---|---|---|---|---|---|---|
| INTERIM | ₹10.00 | 17 Nov 2016 | 19 Nov 2016 | — | FY17 | BSE + NSE |
| INTERIM | ₹20.00 | 13 Nov 2014 | 15 Nov 2014 | 02 Dec 2014 | FY15 | BSE + NSE |
| INTERIM | ₹5.00 | 17 Feb 2014 | 19 Feb 2014 | 11 Mar 2014 | FY14 | BSE + NSE |
| INTERIM | ₹5.00 | 07 Nov 2013 | 08 Nov 2013 | — | FY14 | BSE + NSE |
| FINAL | ₹5.00 | 22 Aug 2013 | — | — | FY14 | BSE + NSE |
| FINAL | ₹2.50 | 17 Apr 2008 | — | — | FY09 | BSE + NSE |
| INTERIM | ₹8.75 | 26 Oct 2007 | 29 Oct 2007 | — | FY08 | BSE |
| INTERIM | ₹5.00 | 22 Mar 2007 | 23 Mar 2007 | — | FY07 | NSE |
| FINAL | ₹7.50 | 28 Apr 2004 | — | — | FY05 | BSE |
| FINAL | ₹4.33* | 22 Apr 2002 | — | — | FY03 | BSE |
| FINAL | ₹2.00* | 15 May 2001 | — | — | FY02 | BSE |
Amounts marked *were restated for a later split or bonus so they compare with today’s shares. Switch to “as filed” to see what was actually declared at the time — that is the figure on an old broker statement.
Other corporate actions
2 on record| Action | Ratio | Ex-date | Record date |
|---|---|---|---|
| Rights issue | 3:10 — 3 share offereds for every 10 held | 08 Mar 2022 | 09 Mar 2022 |
| Bonus issuehistory adjusted | 1:2 — 1 free share for every 2 held | 28 Apr 2004 | — |
Splits and bonuses change the share count, so payouts declared before one are restated in the chart above to stay comparable. Buybacks, rights issues and mergers are listed for reference and do not affect those figures.